Methodological considerations for centromere copy number analyses in HER2-positive metastatic breast cancer

Oncogene. 2026 Jun;45(20):1952. doi: 10.1038/s41388-026-03793-x. Epub 2026 Apr 16.
No abstract available

Publication types

  • Letter